532067 — 3B Blackbio DX Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeSmall CapHigh Flyer

Annual income statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	R2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	233	289	2,267	806	618
Cost of Revenue
Gross Profit	124	156	1,752	490	439
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	166	201	774	442	336
Operating Profit	66.7	87.9	1,494	364	283
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	69.5	101	1,520	432	353
Provision for Income Taxes
Net Income After Taxes	52.4	76.9	1,139	322	259
Minority Interest
Net Income Before Extraordinary Items
Net Income	52.4	76.9	1,139	322	261
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	52.4	76.9	1,139	322	261
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	8.2	10.3	152	43	30.3
Dividends per Share
Special Dividends per Share